GHRS vs MNKD: stock comparison and AI forecast
Gh Research Plc (GHRS) and Mannkind Corp (MNKD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
GHRS Gh Research Plc
- Price
- $20.28 -4.7% · 6M
- Market Cap
- $1.26B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
MNKD Mannkind Corp
- Price
- $3.73 +30.4% · 6M
- Market Cap
- $1.20B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- GHRS and MNKD have similar market capitalizations ($1.26B and $1.20B).
- Over the last six months MNKD returned +30.4% and GHRS -4.7%.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | GHRS | MNKD |
|---|---|---|
| Market Cap | $1.26B | $1.20B |
| EPS | $-1.36 | $-0.04 |
| Revenue/Share | – | $1.22 |
| FCF/Share | $-1.63 | $-0.06 |
Profitability & Margins
| Metric | GHRS | MNKD |
|---|---|---|
| ROE | -29.4% | – |
| ROA | -28.6% | – |
| ROIC | -37.4% | 1.6% |
| Gross Margin | – | 89.8% |
| Operating Margin | – | 2.3% |
| EBT Margin | – | -12.4% |
| Tax Rate | 0.0% | 10.4% |
Financial Health
| Metric | GHRS | MNKD |
|---|---|---|
| Current Ratio | 34.13x | 1.72x |
| Quick Ratio | – | 1.41x |
| D/E Ratio | 0.03x | – |
| Financial Leverage | 1.03x | – |
| Working Capital | $278M | $103M |
Cash Flow
| Metric | GHRS | MNKD |
|---|---|---|
| Operating Cash Flow | -$101M | -$8M |
| Free Cash Flow | -$101M | -$18M |
| Capital Spending | -$290K | -$10M |
| OCF Growth YoY | – | -123.3% |
| FCF Growth YoY | – | -163.0% |
| FCF/Sales | – | -4.6% |
| CapEx/Sales | – | 2.6% |
Operational Efficiency
| Metric | GHRS | MNKD |
|---|---|---|
| Asset Turnover | – | 0.54x |
| Receivables Turnover | – | 9.1x |
| Inventory Turnover | – | 0.9x |
| Fixed Assets Turnover | – | 4.6x |
| Days Sales Outstanding | – | 40 days |
| Days Inventory | – | 402 days |
| Payables Period | – | 100 days |
| Cash Conversion Cycle | – | 342 days |
Income Statement
| Metric | GHRS | MNKD |
|---|---|---|
| Total Revenue | – | $394M |
| Operating Income | -$105M | $9M |
| Net Income | -$82M | – |
| R&D Expense | $66M | $77M |
| SG&A Expense | $39M | $200M |
| Cost of Goods Sold | – | $40M |
Dividend & Shareholder Information
| Metric | GHRS | MNKD |
|---|---|---|
| Shares Outstanding | 62M | 322M |
| EPS Growth | – | -136.4% |
GHRS vs MNKD: stock comparison and AI forecast
Which is bigger, GHRS or MNKD?
GHRS and MNKD have similar market capitalizations ($1.26B and $1.20B).
Which stock performed better over the last six months, GHRS or MNKD?
Over the last six months MNKD returned +30.4% and GHRS -4.7%.
Which one does Intratio's AI model rank higher, GHRS or MNKD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.